Altered expression of transforming growth factor-alpha: an early event in renal cell carcinoma development

J I Everitt1, C L Walker, T W Goldsworthy

  • 1Department of Experimental Pathology and Toxicology, Chemical Industry Institute of Toxicology, Research Triangle Park, North Carolina, USA.

Insights

Altered expression of transforming growth factor-alpha (TGF-alpha) is an early event in renal cell tumor development. This protein may be a key feature of the transformed cell phenotype in renal oncogenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Regulation

Background:

  • Transforming growth factor-alpha (TGF-alpha) is a key regulator of cell growth and differentiation.
  • Altered TGF-alpha expression and its receptor are linked to renal cell carcinomas.
  • The timing of TGF-alpha dysregulation in renal oncogenesis remains unclear.

Purpose of the Study:

  • To investigate whether altered TGF-alpha expression occurs early or late in renal tubular oncogenesis.
  • To analyze TGF-alpha expression in preneoplastic lesions of renal cell carcinoma.

Main Methods:

  • Immunohistochemical analysis of TGF-alpha expression.
  • Utilized a rat model of hereditary renal cell carcinoma.
  • Examined TGF-alpha in various stages of tumor development and in non-neoplastic regenerating tissue.

Main Results:

  • Strong TGF-alpha immunoreactivity was observed in all stages of renal cell tumor development, including early dysplastic lesions.
  • Non-neoplastic regenerating renal tubules, despite similar proliferative capacity, did not show TGF-alpha staining.
  • Altered TGF-alpha expression is an early indicator in renal tumor progression.

Conclusions:

  • Altered TGF-alpha expression is an early event in renal tubular oncogenesis.
  • TGF-alpha may play a significant role in the transformed phenotype of renal cells.
  • This finding has implications for understanding early cancer development.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...